Business Wire

HCL and UpLink Call for Applications Globally for Second Challenge of Aquapreneur Innovation Initiative

21.8.2023 15:24:00 EEST | Business Wire | Press release

Share

HCL, a global conglomerate and UpLink, the open innovation platform of the World Economic Forum, announced opening the applications for the Zero Water Waste Challenge – part of the Aquapreneur Innovation Initiative. The challenge calls for innovative water usage approaches to improve freshwater conservation from supply to demand, moving towards zero water waste. At the end of the challenge, 10 winners will receive a total financial award of 1.75M CHF.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230821935081/en/

Important Dates to Note

21 August to 2 October 2023

Open for submissions

17 October to 15 November 2023

Review and selection process

January 2024

Announcement of the winning Top Innovators

This is the second challenge out of five Challenges of the HCL and UpLink’s Aquapreneur Innovation Initiative. Launched last year at Davos in May 2022, to create a first-of-its-kind innovation ecosystem for the global freshwater sector. The last date to apply for the second-year challenge is October 2nd, 2023. Full details and eligibility criteria can be found at this link. Under this initiative HCL committed $15 million until 2027 to support the water-focused entrepreneurs.

Roshni Nadar Malhotra, Chairperson, HCLTech said, As the climate change continue to intensify and fresh-water resources become scarcer, the corporates have a unique opportunity to make a substantial difference in the world we live in. At HCL, we are committed to help resolve this global crisis. In partnership with UpLink, we are all set to announce the second edition of our Aquapreneur Innovation Initiative moving towards zero water waste. While our commitment to this vital cause is unwavering, we invite fellow organizations to join us in this shared mission, contributing essential funding and catalyzing widespread exposure.”

Gim Huay Neo, Managing Director of the Centre for Nature and Climate at the World Economic Forum said, The Aquapreneur Innovation Initiative is building a vibrant innovation ecosystem for water which is crucial for the conservation and restoration of all-natural ecosystems. By connecting innovators, experts, investors and partners, this initiative is fast-tracking high-impact solutions to enhance water security. Already, we’re seeing significant impact with the ten winners of the first Innovation Challenge and we’re excited to surface and support a new cohort of aquapreneurs .”

The focus of this year’s challenge will be on:

  • Capturing and protecting freshwater supply

Protecting groundwater reservoirs by capturing additional water resources. Solutions could focus on recharging groundwater, capturing storm- and rainwater or water from the atmosphere, preventing or minimizing leakages, boosting ecosystem resilience or monitoring and managing freshwater.

  • Water re-use and recycling of materials

Increase water-efficiency by reusing and recycling water resources. Solutions could include products that enable shower, washing machine and sink water to be recycled for non-potable uses, or reuse of water in industrial facilities, cleaner and greener tech to purify reused water, etc. Ideally need to manage trade-offs, e.g. need to have sustainable energy support, as well as focus on water quality.

  • Saving water in agriculture

Reduce water withdrawal in agriculture through smart irrigation. Solutions could include precision irrigation, remote sensing, regenerative agricultural practices focused on water retention, and technologies such as mobile applications to optimize the amount and timing of water applied to crops. ​

Evaluation and selection criteria for 2nd year will include:

I. Organizational structure

  • Financially viable business model: solution demonstrates a sustainable business model and revenue approach, and presents proof of funding history, as well as investable opportunities for investors or philanthropic funders.
  • Stage: beyond the ideation phase and demonstrating the potential to scale and achieve long-term financial viability, impact, and sustainability. UpLink Top Innovators have typically reached the pilot to growth/scale phase of their operations.
  • Management team: committed, diverse and values driven management team with the right skillset and demonstrated execution capabilities, and including local staff, or the willingness to work with local stakeholders.
  • Measurement and standards verification: solution demonstrates a clear impact monitoring, evaluation, and verification framework. The metrics and indicators should be tracked transparently, reference and apply relevant, robust standards, and receive independent credentialing and third-party verification.
  • Governance and operating models: solution has a legal entity attached to the project or technology. The operating model shows the extent to which the project has achieved financial viability and sustainable revenue streams or has a vision and plan for achieving it.

II. Key characteristics:

  • Innovative: while many water technologies already exist, innovation is needed in service, pricing, partnerships, and business models.
  • Replicability: submissions from across the globe that are scalable in their local contexts and potentially replicable in different parts of the world.
  • Holistic and sustainable impact: solution demonstrates ‘win-win’ benefits for multiple agendas, particularly society and the environment. Solution supports the water agenda in the long term, delivering impact that outlasts the length of the challenge.
  • External risk: solution is aware of any risks and uncertainties associated with achieving the desired outcomes.

Top 10 water-focused entrepreneurs will be selected as Top Innovators to join the UpLink Innovation Network, an exclusive program tailored for Founders, CEOs, Executive Directors, and more. They will get various benefits, including access to selected events, projects, and communities led by the World Economic Forum and its partners. Participants will gain strategic connections with organizations within the Forum's and UpLink's networks, fostering valuable collaborations. The program extends targeted support encompassing technical, business, and operational guidance. Notably, a financial incentive is provided – among the selected Top Innovators, up to 10 can each receive 175,000 CHF from a total fund of 1.75 million CHF.

About HCL Group

Founded in 1976 as one of India’s original IT garage start-ups, HCL is a pioneer of modern computing with many firsts to its credit, including the introduction of the 8-bit microprocessor-based computer in 1978 well before its global peers. Today, the HCL enterprise has a presence across varied sectors that include technology, healthcare and talent management solutions and comprises three companies – HCL Infosystems, HCL Technologies and HCL Healthcare. The enterprise generates annual revenues of over US$12.8 billion with over 223,438 employees operating across 60 countries. For further information, visit www.hcl.com

About UpLink

UpLink is the open innovation platform of the World Economic Forum, dedicated to unlocking an ‘entrepreneur revolution’ to support positive systemic change for people and planet. Launched at the Forum’s Annual Meeting in Davos in January 2020 in collaboration with Salesforce and Deloitte, UpLink is now a thriving ecosystem of 400+ Top Innovators, investors, experts, and organizations, who are driving positive impact for the UN Sustainable Development Goals.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Dr. Pooja Arora | pooja_sikka@hcl.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release

2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr

Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release

Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye